Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Angelos Evangelinos"'
Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction
Autor:
Lewis J. Renshall, Frances Beards, Angelos Evangelinos, Susan L. Greenwood, Paul Brownbill, Adam Stevens, Colin P. Sibley, John D. Aplin, Edward D. Johnstone, Tambet Teesalu, Lynda K. Harris
Publikováno v:
Pharmaceutics, Vol 13, Iss 11, p 1778 (2021)
Placental dysfunction is the underlying cause of pregnancy complications such as fetal growth restriction (FGR) and pre-eclampsia. No therapies are available to treat a poorly functioning placenta, primarily due to the risks of adverse side effects i
Externí odkaz:
https://doaj.org/article/31d09fe8761e42b3bf935d5bee54fcfc
Autor:
Gianfranco Pasut, Frances Beards, Francesca Greco, Abbie Dodd, Az Alddien Natfji, Antonella Grigoletto, Lewis Renshall, Lynda K. Harris, Helen M. I. Osborn, Angelos Evangelinos
Publikováno v:
Molecular Pharmaceutics. 19:345-353
Here, we evaluated the feasibility of non-prodrug PEG-drug conjugates to decrease the accumulation of drugs within the placental tissues. The results showed that PEG was biocompatible with the human placenta with no alteration of the basal rate of pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2666a0c847581476cb6e3b341d4656e7
https://doi.org/10.1021/acs.molpharmaceut.1c00498
https://doi.org/10.1021/acs.molpharmaceut.1c00498
Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction
Autor:
Adam Stevens, John D. Aplin, Edward D. Johnstone, Susan L. Greenwood, Tambet Teesalu, Colin P. Sibley, Lynda K. Harris, Angelos Evangelinos, Frances Beards, Lewis Renshall, Paul Brownbill
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 13, Iss 1778, p 1778 (2021)
Renshall, L J, Beards, F, Evangelinos, A, Greenwood, S L, Brownbill, P, Stevens, A, Sibley, C P, Aplin, J D, Johnstone, E D, Teesalu, T & Harris, L K 2021, ' Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction ', Pharmaceutics, vol. 13, no. 11, pp. 1778 . https://doi.org/10.3390/pharmaceutics13111778
Volume 13
Issue 11
Pharmaceutics, Vol 13, Iss 1778, p 1778 (2021)
Renshall, L J, Beards, F, Evangelinos, A, Greenwood, S L, Brownbill, P, Stevens, A, Sibley, C P, Aplin, J D, Johnstone, E D, Teesalu, T & Harris, L K 2021, ' Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction ', Pharmaceutics, vol. 13, no. 11, pp. 1778 . https://doi.org/10.3390/pharmaceutics13111778
Volume 13
Issue 11
Placental dysfunction is the underlying cause of pregnancy complications such as fetal growth restriction (FGR) and pre-eclampsia. No therapies are available to treat a poorly functioning placenta, primarily due to the risks of adverse side effects i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d83bd3651a6013bd804feb29a326f206
http://europepmc.org/articles/PMC8618188
http://europepmc.org/articles/PMC8618188